Can testosterone therapy be offered to men on active surveillance for prostate cancer? Preliminary results

Can testosterone therapy be offered to men on active surveillance for prostate cancer? Preliminary results

This report presents our experience with T therapy in a cohort of T-deficient men on active surveillance (AS) for Gleason 3 + 3 and Gleason 3 + 4 prostate cancer (PCa). A retrospective chart review identified 28 men with T deficiency who underwent T therapy (T group) for at least 6 months while on A...

Full description

Bibliographic Details
Main Authors: Ravi Kacker, Mariam Hult, Ignacio F San Francisco, William P Conners, Pablo A Rojas, William C Dewolf, Abraham Morgentaler
Format: Article
Language:English
Published: Wolters Kluwer Medknow Publications 2016-01-01
Series:Asian Journal of Andrology
Subjects:
active surveillance; prostate cancer; testosterone
Online Access:http://www.ajandrology.com/article.asp?issn=1008-682X;year=2016;volume=18;issue=1;spage=16;epage=20;aulast=Kacker

Internet

http://www.ajandrology.com/article.asp?issn=1008-682X;year=2016;volume=18;issue=1;spage=16;epage=20;aulast=Kacker

Similar Items